Table 5.
Classification of LSPD by different diagnostic criteria using MDS PDD Level II criteria as the gold-standard.
| Classification | MDS PDD Level I | DSM-IV | DSM-5 MMSE adjusted for education |
DSM-5 MMSE adjusted for age and education |
DSM-5 MMSE adjusted for dementia | DSM-5 NPA |
|---|---|---|---|---|---|---|
| True positive | 3 | 45 | 52 | 54 | 49 | 54 |
| False positive | 0 | 5 | 0 | 3 | 2 | 5 |
| True negative | 30 | 25 | 30 | 27 | 28 | 23 |
| False negative | 31 | 9 | 2 | 0 | 5 | 0 |
| PPV (%) | 100 | 90.0 | 100 | 94.7 | 96.1 | 91.5 |
| NPV (%) | 49.2 | 73.5 | 93.8 | 100 | 84.8 | 100 |
| Sensitivity (%) | 8.8 | 83.3 | 96.3 | 100 | 90.7 | 100 |
| Specificity (%) | 100 | 83.3 | 100 | 90.0 | 93.3 | 82.1 |
| Kappa coefficient* | 0.1 | 0.6 | 0.9 | 0.9 | 0.8 | 0.9 |
LSPD, Late-stage Parkinson's Disease patients; MDS PDD, Parkinson's Disease dementia criteria recommended by Movement Disorder Society Task Force (11); DSM-IV, Parkinson's Disease dementia criteria recommended by Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition (15); DSM-5, Parkinson's Disease dementia criteria recommended by Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (16); MMSE, Mini-Mental State Exam; NPA, Neuropsychological assessment; PPV, Positive Predictive Value; NPV, Negative Predictive Value.
Kappa coefficient >0.6 is significant.